# Short-Term Alpha Lipoic Acid Therapy for Prevention of Contrast-induced Acute Kidney Injury and Endothelial Dysfunction in Type 2 Diabetes

> **NCT01978405** · PHASE4 · UNKNOWN · sponsor: **Xiang Guang-da** · enrollment: 200 (estimated)

## Conditions studied

- Acute Kidney Injury
- The Changes of Plasma Creatinine
- The Changes of Plasma Free Radicals
- The Changes of Endothelium-dependent Arterial Dilation

## Interventions

- **DRUG:** Alpha lipoic acid

## Key facts

- **NCT ID:** NCT01978405
- **Lead sponsor:** Xiang Guang-da
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-11
- **Primary completion:** 2014-06
- **Final completion:** 2014-06
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2013-11-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01978405

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01978405, "Short-Term Alpha Lipoic Acid Therapy for Prevention of Contrast-induced Acute Kidney Injury and Endothelial Dysfunction in Type 2 Diabetes". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT01978405. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*